COMMUNIQUÉS West-GlobeNewswire

-
BioPorto to redraw U.S. application for regulatory clearance of The NGAL Test™ for risk assessment for AKI in patients under the age of 22 with the intend to resubmit in Q4 2019
13/07/2019 -
Aras Azadian, Setu Purohit and Kyle Langstaff Announce Positions in Avicanna Inc.
13/07/2019 -
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2019 Annual Meeting of Stockholders
12/07/2019 -
HealthEquity Announces Closing of Follow-On Offering and Over-Allotment Option
12/07/2019 -
Eton Pharmaceuticals Provides Update on EM-100 Program
12/07/2019 -
Extendicare Announces Timing of 2019 Second Quarter Results and Conference Call
12/07/2019 -
RECORDATI TO ACQUIRE WORLDWIDE RIGHTS TO SIGNIFOR® AND OSILODROSTAT (LCI699)
12/07/2019 -
Spineway : Notice of the Ordinary and Extraordinary General Shareholders’ Meeting to be held 24 July 2019
12/07/2019 -
SPINEWAY : Convocation à l'Assemblée Générale Mixte du 24 juillet 2019
12/07/2019 -
DLT Resolution Inc. Delayed Financial Reporting F18 10K and Q1 2019 Update
12/07/2019 -
Genmab Announces Submission of Biologics License Application to U.S. FDA for Subcutaneous Formulation of Daratumumab
12/07/2019 -
Overturning ObamaCare Would Benefit Americans, Association of American Physicians and Surgeons (AAPS) Tells President and Congress
12/07/2019 -
Todos Medical to Appoint Dr. Paula Trzepacz As Chief Medical Officer And Files New Patent Application
12/07/2019 -
HMS to Report Second Quarter Financial Results on August 2, 2019
12/07/2019 -
Olainfarm Group sales in the first half of the year increased by 7%
12/07/2019 -
NeuBase Therapeutics Closes Merger Transaction with Ohr Pharmaceutical
12/07/2019 -
Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders
12/07/2019 -
Generex Biotechnology Announces Closing on Acquisition of MediSource Partners
12/07/2019 -
Sonoma Pharmaceuticals Regains Compliance with Nasdaq® Minimum Bid Price Rule
12/07/2019
Pages